Sbir phase II: development of bioengineered anticoagulant heparin from a non-animal source
Ended Cooperative Agreement Awarded Last action
- Award ID
- 2026188
- Recipient
-
Tega Therapeutics Inc. UEI C1LJLCS3PM51
- Awarding agency
-
National Science Foundation
- Obligated
- $1,394,931
Award facts
- Assistance listing
- 47.084 NSF Technology, Innovation, and Partnerships
- Completion date
- Originally
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $199,699 | |
| Amendment | $195,284 | |
| Original award | $999,948 |
Quick answers
Who received award 2026188?
2026188 was awarded to Tega Therapeutics Inc. by National Science Foundation on December 15, 2020.
How much is award 2026188 worth?
$1,394,931 has been obligated on 2026188.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award